Columbia Care Announces Upcoming Conference Participation

NEW YORK--(BUSINESS WIRE)--Sep. 11, 2023--Columbia Care Inc.(NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in theU.S., today announced that it will be participating in the following upcoming conferences:

September 2023

  • ATB 2023Life Sciences Institutional Investor Conference,New York, NYSeptember 20, 2023
  • Benzinga Cannabis Capital Conference,Chicago, ILSeptember 27, 2023

October 2023

  • A.G.P.’sVirtual Cannabis Conference, Virtual –October 4, 2023
  • Jefferies CannabisSummit, New York, NY –October 25, 2023

At each event, members of the management team will participate in fireside chats and host one-on-one investor meetings.

For additional information, please visit the Investor Relations section of the Company’s website at:

AboutColumbia Care

Columbia Careis one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 16 U.S. jurisdictions.Columbia Careoperates 125 facilities including 94 dispensaries and 31 cultivation and manufacturing facilities, including those under development.Columbia Careis one of the original multi-state providers of medical cannabis in theU.S.and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. For more information onColumbia Care, please visit

Lee Ann Evans
SVP, Capital Markets

Lindsay Wilson
SVP, Communications

Source:Columbia Care Inc.

<< Back to Press Releases